← FDA ENFORCEMENT
D-0330-2026Class II

F.H. INVESTMENTS, Inc. (dba Asteria Health)

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Product type
Drug
Status
Ongoing
Report date
2026-02-18
Distribution
Nationwide in the USA
Firm state
AL
Product quantity
1,631 pellets
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Presence of Foreign substance - potential presence of metal particulate matter

Product description

Testosterone 87.5mg, Triamcinolone Acetonide17.5 mcg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-6087-32.

Code / lot info

Lot#: 256000103, Exp. 07/28/2026.

Other recalls SPEQ maps to Environmental Monitoring
See all Environmental Monitoring recalls →

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →